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Metoprolol, 1-isopropylamino-3-[4-(2-methoxy-ethyl)-phenoxy]-2-propanol, is a b1-
-selective aryloxy propanolamine used in the treatment of cardiovascular disorders such
as hypertension, arrhythmia and heart failure (1). The drug is a lipophilic adrenorecep-
tor antagonist (b-blocker) with a short half-life.
Various methods reported for the determination of metoprolol and its metabolites
in human plasma include gas chromatography (GC) equipped with an electron capture
detector (ECD) (2), nitrogen selective detector (NSD) (3), mass spectrometry (MS) detec-
tor (4, 5) and high performance liquid chromatography equipped with a ultra violet de-
tector (6, 7), fluorescence detector (8–12), MS detector (13–15). Sample preparation for
the extraction of metoprolol from human plasma is based on the solid phase extraction
(4) and liquid-liquid extraction using dichloro methane (2, 8, 10, 12), n-butyl chloride
(11) and mixture of dichloromethane and diethyl ether (2, 8).
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A high-performance liquid chromatography-tandem
mass spectrometric method was developed and valida-
ted for the determination of metoprolol in human plas-
ma. The analyte and internal standard, nevirapine, were
extracted from plasma matrix by liquid-liquid extraction
with ethyl acetate. Chromatographic separation was ac-
hieved on a C-18 analytical column with an isocratic mo-
bile phase of 15:85 (V/V) 10 mmol L–1 ammonium aceta-
te (pH 5.0)/acetonitrile. The atmospheric pressure chemi-
cal ionization technique was used for sample ionization
in positive ion mode and enhanced selectivity was achie-
ved by tandem mass spectrometric analysis via two mul-
tiple reaction monitoring (MRM) transitions, 268.2 
116.2 for metoprolol and 267.1  226.2 for nevirapine,
respectively. The assay was validated for human plasma
over a concentration range of 1–200 ng mL–1 with the pre-
cision and accuracy ranging from 0.9 to 8.8 % and 89.9 to
105.8 %, respectively.
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In the present work we developed a reverse phase liquid chromatography and tan-
dem mass spectrometric method which is more sensitive (LOQ of 1 ng mL–1) than the
methods reported in the literature using less plasma sample volume (100 mL). The liq-
uid-liquid extraction method was used for extraction of analyte and internal standard,
which is time saving. The method was validated by evaluating parameters such as the
linearity of chromatographic response, precision, accuracy.
EXPERIMENTAL
Chemicals
Metoprolol succinate obtained from Degussa (India), nevirapine from Cipla, (India),
ethyl acetate (AR grade) from Qualigens (India), ammonium acetate (AR grade) from
Merck (India), acetonitrile and water (HPLC grade) from Merck (India) were used in this
analysis. K3HEDTA (Sigma Aldrich, India) was used as anti-coagulant.
Instrumentation and LC-MS/MS conditions
The HPLC system consisted of an Agilent Technologies 1100 series system equipped
with a binary pump, vacuum degasser, column oven and an auto sampler (Agilent Tech-
nologies Inc, USA). Mass spectrometric detection was performed using an API 3200 (tri-
ple quadrupole) instrument from Applied Bio Systems (MDS SCIEX, Canada) with an
APCI interface. The data acquisition and control system was created using the Analyst
1.4.2 software from Applied Bio Systems. The main working parameters of the mass spec-
trometer are summarized in Table I. Nitrogen was produced using an on-site nitrogen
generator from PEAK Scientific, UK. A C18 analytical column (Purospher Star, 4.6 ´ 150
mm, 5 mm) (Merck) was used. All chromatography experiments were carried out in iso-
178
P. Venkateswarlu et al.: Selective and sensitive method for the determination of metoprolol in human plasma using liquid
chromatography coupled with tandem mass spectrometry, Acta Pharm. 60 (2010) 177–184.
Table I. Tandem mass spectrometer main working parameters
Parameter Value
Source temperature (°C) 500
Dwell time per transition (ms) 200
Source gas (Pa) 344740
Curtain gas (Pa) 137896
Collision gas (Pa) 20684
Nebulizer current (mA) 5
Declustering potential (V) 50 (analyte), 52 (IS)
Collision energy (V) 25 (analyte), 35 (IS)
Collision cell exit potential (V) 3 (analyte), 7 (IS)
Mode of analysis Positive
Ion transitions for metoprolol (m/z) 268.2  116.2
Ion transitions for nevirapine (m/z) 267.1  226.2
cratic mode. The mobile phase, consisting of 10 mmol L–1 ammonium acetate (pH 5.0)/
acetonitrile (15:85, V/V) was pumped at a flow rate of 1 mL min–1. The injection volume
was 20 mL and the total run time was 3 min.
Preparation of standards and quality control samples
Stock solutions of metoprolol (1 mg mL–1) and internal standard (IS) nevirapine (1
mg mL–1) were separately prepared in 5-mL volumetric flasks with acetonitrile. The in-
ternal standard working solution (1 mg mL–1) was prepared by diluting its stock solution
with water/acetonitrile (1:1). The working standard solution of metoprolol (50 mL) was
added to 950 mL drug free plasma to obtain metoprolol concentration levels of 1, 2, 5, 10,
25, 50, 100 and 200 ng mL–1.
Sample preparation
The plasma sample (100 mL) was transferred into a vial and then 10 mL of internal
standard (1 mg mL–1) working solution was added. After vortexing for 30 s, 2.5 mL of ex-
traction solvent, ethyl acetate, was added to the sample. The samples were vortexed on a
shaker for 10 min and the supernatant (organic layer) was transferred into another vial.
Ethyl acetate layer was evaporated under a stream of nitrogen at 40 °C. The dried resi-
due was reconstituted with 100 mL of mobile phase and vortexed. The sample was loa-
ded into auto-injector vials and 20 mL aliquots were injected into the chromatographic
system.
Method validation
The selectivity of the method was determined by analyzing blank plasma, without
addition of metoprolol and IS. Three analytical batches were used to assess the precision
and accuracy of the method. Each batch contained a single set of calibration standards
and six replicates of regular quality control (QC) samples at three concentrations (3, 80
and 160 ng mL–1). The assay precision for each QC level was determined as the relative
standard deviation (RSD) of the measured concentrations and the accuracy was expre-
ssed as percentage of the mean of measured concentrations over the nominal concentra-
tion. The intra- and inter-batch precisions were required to be below 15 %, and accuracy
within ± 15 %. For LLOQ, the precision required should be below 20 % and accuracy
within ± 20 % (16).
RESULTS AND DISCUSSION
Method development
Optimization of tandem mass spectrometry conditions. – Direct infusion method was
used for optimization of compound parameters. Methanolic solutions of metoprolol and
nevirapine at a concentration of 100 ng mL–1 were used. In this mode, the parent ion,
source parameters such as ion spray voltage, curtain gas and compound parameters de-
clustering potential, focusing potential were optimized, and then the product ion was
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optimized using product ion scan. Product ion formation was achieved by using colli-
sion gas. MRM scan mode was used for optimization of collision energy, collision cell
exit potential. Flow injection analysis method was used for optimizing the source gas
and source temperature. Here, 10 mmol L–1 ammonium acetate buffer and acetonitrile
solution (15:85) was used at a 1.0 mL min–1 flow rate and without column. All optimized
mass spectrometry parameters are summarized in Table I.
Optimization of chromatographic conditions. – The chromatographic conditions were
optimized through several trials to achieve good resolution and symmetric peaks of ana-
lyte and IS as well as a short run time. The mobile phase pH 5 was found to be necessary
for good sensitivity and peak shape. High proportion of organic solvent [10 mmol L–1
ammonium acetate (pH 5.0)/acetonitrile (15:85, V/V)] eluted the analyte and the IS at
retention times of 1.64 and 1.75 min, respectively.
Optimization of extraction. – Four organic solvents, diethyl ether, hexane, ethyl ace-
tate and dichloromethane were used in the extraction process. Ethyl acetate was found
to be optimal; it can produce a clean chromatogram for a blank plasma sample and yield
the highest analyte recovery from the plasma.
Method validation
The selectivity of the method was examined by analyzing (n = 6) blank human
plasma extracts. As shown in Fig. 1a, there was no significant interference in the blank
plasma at analyte retention time. Fig. 1b depicts a representative chromatogram for me-
180
P. Venkateswarlu et al.: Selective and sensitive method for the determination of metoprolol in human plasma using liquid






















Fig. 1. MRM chromatograms of: a) blank (drug and IS free human plasma), b) plasma spiked with
metoprolol at LLOQ level (1 ng mL–1) and IS (1 mg mL–1).
toprolol at the LLOQ level (1 ng mL–1). Excellent sensitivity was observed for a 20 mL in-
jection volume.
The eight-point calibration curve was linear over the concentration range 1–200 ng
mL–1 metoprolol. The best linear fit and least-squares residuals for the calibration curve
were achieved with a 1/x weighing factor, giving the mean linear regression equation
y = 0.0007x + 0.0050 where y is the peak area ratio of the metoprolol to the IS and x is the
metoprolol concentration (ng mL–1). The mean correlation coefficient of the weighted ca-
libration curve generated during the validation was 0.9995 (± 0.0003); Table II summa-
rizes the calibration data.
The LLOQ was defined as the lowest concentration in the standard curve that can
be measured with acceptable accuracy and precision and was found to be 1 ng mL–1 in
human plasma. The mean peak area for the analyte peak at LLOQ (1 ng mL–1) was ~10-
-fold greater than the mean peak area for the blank human plasma samples at the ana-
lyte retention time. The imprecision and accuracy at LLOQ level were 9.2 and 90.2 %. For
the within-batch experiments, the repeatability RSD and accuracy ranged from 0.9 to
8.8 % and accuracy from 89.9 to 105.8 % as shown in Table III.
Recovery of the metoprolol from the extraction procedure was examined by com-
paring the detector response obtained from the processed (extracted) sample and the de-
tector response obtained for direct injection of standard solution. Recovery experiment
was performed at three concentration levels (low, medium and high) with six replicates.
The mean recovery for metoprolol at three different concentrations was 78.0 %. The re-
covery of IS was 77.6 % at the concentration used in the assay (100 ng mL–1). The reco-
very of analyte and IS was consistent.
The analytical performance of the proposed method for the determination of me-
toprolol in human plasma was compared with HPLC methods reported in the literature
and the values are presented in Table IV. These values indicate that the present method
has several advantages over the reported methods in terms of the plasma volume used
for extraction, total run time, recovery of metoprolol and LOQ. For example Gowda et al.
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Table II. Precision and accuracy data of back-calculated concentrations of calibration standards for
metoprolol in human plasma
Concentration added to
blank plasma (ng mL–1)
Concentration found
(ng mL–1)a
Precision (RSD, %) Accuracy (%)
1.01 0.97 ± 0.084 8.7 95.9
2.02 2.01 ± 0.140 7.0 99.2
5.05 5.17 ± 0.184 3.6 102.4
10.10 10.01 ± 0.555 5.5 99.1
25.25 25.31 ± 0.767 3.0 100.2
50.50 51.72 ± 0.716 1.4 102.4
101.01 103.49 ± 2.414 2.3 102.5
202.01 198.28 ± 3.735 1.9 98.2
a Mean ± SD, n = 5.
(14) reported LC-MS/MS method with limit of quantitation (LOQ) of 5 ng mL–1 for me-
toprolol by using 250 mL of plasma for sample preparation.
In the present work we developed a reverse phase liquid chromatography and tan-
dem mass spectrometric method which is more sensitive (LOQ of 1 ng mL–1) than the
methods reported in the literature using less plasma sample volume (100 mL).
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Table III. Precision and accuracy data of the LC-MS/MS method for determining





Precision (RSD, %) Accuracy (%)
Batch 1 3.03 3.05 ± 0.267 8.8 100.6
80.86 85.53 ± 5.495 6.4 105.8
161.72 164.86 ± 12.076 7.3 101.9
Batch 2 3.03 2.79 ± 0.092 3.3 91.8
80.86 73.06 ± 1.841 2.5 90.4
161.72 145.39 ± 1.863 1.3 89.9
Batch 3 3.03 2.92 ± 0.111 3.8 96.3
80.86 78.86 ± 0.730 0.9 97.5
161.72 159.72 ± 2.539 1.6 98.8
Inter batch 3.03 2.92 ± 0.199 6.8 96.2
80.86 79.15 ± 6.125 7.7 97.9
161.72 156.66 ± 10.847 6.9 96.9
a Mean ± SD, n = 6.
Table IV. Comparision of analytical performances of the present method for metoprolol with HPLC












LLE (ethyl acetate) 500 More than 77 40 25 6
LLE (chloroform/penta-
nol/diethyl ether, 6:2:1)
1000 – 26 25 7
SPE 1000 – 14 1 9
LLE (dichloromethane) 500 – – 10 10
LLE (n-butyl chloride) 1000 74 8 5 11
LLE (dichloromethane) 1000 – 9 10 12
LLE (diethyl ether/
dicloromethane 70:30)
250 78 5 5 14
LLE (ethyl acetate) 100 78 3 1 this paper
LLE – liquid-liquid extraction; SPE – solid phase extraction.
CONCLUSIONS
A sensitive, accurate and precise method based on LC-MS/MS for the determina-
tion of metoprolol in human plasma with LLOQ of 1 ng mL–1 level is described. The
method can be used for the determination of metoprolol in the range of 1–200 ng mL–1
in human plasma.
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S A @ E T A K
Selektivna i osjetljiva metoda odre|ivanja metoprolola u humanoj plazmi
teku}inskom kromatografijom spregnutom s masenom spektrometrijom
PADALA VENKATESWARLU, BOMMANA NARESH KUMAR, KALLURU SESHAIAH i VASI REDDY VERA VARA PRASAD
U radu je opisano odre|ivanje metoprolola u humanoj plazmi teku}inskom kroma-
tografijom visoke u~inkovitosti spregnutom s masenom spektrometrijom. Analit i inter-
ni standard, nevirapin, ekstrahirani su iz plazme etil-acetatom. Kromatografsko odjelji-
vanje provedeno je na C-18 koloni uz mobilnu fazu sljede}eg sastava: 10 mmol L–1
amonijev acetat (pH 5,0)/acetonitril 15:85 (V/V). Ionizacija uzoraka provedena je pri at-
mosferskom tlaku. Pove}anje selektivnosti postignuto je spregnutom masenom spektro-
metrijskom analizom pra}enjem dvaju prijelaza (MRM) – 268,2  116,2 za metoprolol,
odnosno 267,1  226,2 za nevirapin. Metoda je validirana za koncentracijsko podru~je
1200 ng mL–1 uz preciznost i to~nost od 0,9 do 8,8 %, odnosno 89,9 do 105,8 %.
Klju~ne rije~i: metoprolol, teku}inska kromatografija, spregnuta masena spektrometrija, humana
plazma, bioekvivalencija
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